Merlonipharma
Managed Access Program & orphan drugs
Hard-to-find, unlicensed, and in-shortage drugs
In urgent need of expedited service?
We can ship Swiss pharmaceutical products within 1 business day of your order.
The latest headlines
- GlaxoSmithKline wins blockbuster green light with Shingrix, its new shingles vaccine
- Fine-tuning the future: A review of Aldous Huxley’s Brave New World
- WuXi AppTec acquires ResearchPoint Global
- Institut Curie, Pierre Fabre Partner on immuno-oncology
- Phase III Lusutrombopag study shows positive efficacy
- Konica Minolta Closes Ambry Genetics Acquisition
- Celgene cans phase 3 trial of $710M Crohn’s drug GED-0301
- Enanta Pharmaceuticals to Present New Preclinical Data on EDP-305, an FXR Agonist for NASH and …
- Report of Successful OMS721 Treatment of Patient with Both Stem Cell Transplant-Associated …
- Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021 – Key Vendos are ApoCell, …
